MaxCyte, Inc.: cashflow_investing
| Value | {"amount": -24823300, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | superseded |
| Entity | MaxCyte, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:14:32.347225+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1d3742e4-9058-4769-990c-e04034a8b47c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-23-003911Retrieved: 2026-08-19T12:14:32.347225+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001287098/cashflow-investing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1d3742e4-9058-4769-990c-e04034a8b47c
History
- no predecessors — first report